Literature DB >> 30655632

Better end points needed in primary sclerosing cholangitis trials.

Alessio Gerussi1, Pietro Invernizzi2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30655632     DOI： 10.1038/s41575-019-0110-5

Source DB:  PubMed          Journal:  Nat Rev Gastroenterol Hepatol        ISSN： 1759-5045            Impact factor:   46.802


× No keyword cloud information.
  1 in total

Review 1.  Grand round: Autoimmune hepatitis.

Authors:  Palak J Trivedi; Stefan G Hubscher; Michael Heneghan; Dermot Gleeson; Gideon M Hirschfield
Journal:  J Hepatol       Date:  2018-11-20       Impact factor: 25.083
  1 in total
  1 in total

Review 1.  New Therapeutic Targets in Autoimmune Cholangiopathies.

Authors:  Alessio Gerussi; Martina Lucà; Laura Cristoferi; Vincenzo Ronca; Clara Mancuso; Chiara Milani; Daphne D'Amato; Sarah Elizabeth O'Donnell; Marco Carbone; Pietro Invernizzi
Journal:  Front Med (Lausanne)       Date:  2020-04-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.